Akkermansia muciniphila has been associated with improved metabolic markers and immune function in research, with studies exploring its role in obesity and Type 2 diabetes
Research suggests Akkermansia may support intestinal barrier function, which has been studied in relation to inflammatory bowel disease and colorectal cancer risk
Research has explored Akkermansia's relationship with the gut-brain axis and conditions such as anxiety and Alzheimer's disease, primarily in preclinical models
Akkermansia has also been studied for its potential role in stress-related research
Akkermansia supplementation has been studied in two forms (live and pasteurized) in published human trials. The pasteurized form was associated with greater improvements in metabolic markers in a small proof-of-concept study, though larger trials are needed
Podden och tillhörande omslagsbild på den här sidan tillhör
Dr. Mercola. Innehållet i podden är skapat av Dr. Mercola och inte av,
eller tillsammans med, Poddtoppen.
